RECRUITINGOBSERVATIONAL
Recurrent Visceral Leishmaniasis in HIV Co-Infection
New And Recurrent Visceral Leishmaniasis in HIV Co-Infected Ethiopian Patients: a Cohort Study
About This Trial
The aim is (1) to better understand the underlying causes and predispositions for relapse and parasite persistence in visceral leishmaniasis (VL) patients living with HIV and (2) to improve treatment monitoring of this target group in Ethiopia
Who May Be Eligible (Plain English)
Who May Qualify:
1. VL-HIV infection 1.1. VL: microscopically confirmed parasite presence in spleen or bone marrow tissue at first episode or relapse; for known active chronic cases: decision to treat VL 1.2. HIV: confirmed viral infection (new or past)
2. ≥18 years
Who Should NOT Join This Trial:
1. Not willing to provide written willing to sign a consent form
2. Not willing to adhere to the follow-up visits
3. Mentally or physically incapable to participate in the study (to the discretion of the treating physician)
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
1. VL-HIV infection 1.1. VL: microscopically confirmed parasite presence in spleen or bone marrow tissue at first episode or relapse; for known active chronic cases: decision to treat VL 1.2. HIV: confirmed viral infection (new or past)
2. ≥18 years
Exclusion Criteria:
1. Not willing to provide written informed consent
2. Not willing to adhere to the follow-up visits
3. Mentally or physically incapable to participate in the study (to the discretion of the treating physician)
Locations (1)
University of Gondar
Gonder, Ethiopia